Lear (NYSE:LEA – Free Report) had its target price decreased by UBS Group from $146.00 to $142.00 in a report released on Wednesday morning, Benzinga reports. UBS Group currently has a neutral rating on the auto parts company’s stock. Several other brokerages have also issued reports on LEA. Morgan Stanley lifted their price target on […]
Floor & Decor (NYSE:FND – Get Free Report) had its price target dropped by UBS Group from $135.00 to $125.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price would suggest a potential upside of 10.58% from the company’s […]
Amgen (NASDAQ:AMGN – Free Report) had its price objective upped by UBS Group from $284.00 to $307.00 in a research report report published on Friday morning, Benzinga reports. UBS Group currently has a neutral rating on the medical research company’s stock. A number of other analysts also recently issued reports on the stock. Truist Financial […]
Monster Beverage (NASDAQ:MNST – Free Report) had its target price trimmed by UBS Group from $61.00 to $60.00 in a research note released on Friday morning, MarketBeat.com reports. The brokerage currently has a neutral rating on the stock. MNST has been the topic of several other reports. Deutsche Bank Aktiengesellschaft lowered their price objective on […]
Amgen (NASDAQ:AMGN – Free Report) had its price target boosted by UBS Group from $284.00 to $307.00 in a report released on Friday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. AMGN has been the subject of a number of other reports. William Blair upgraded Amgen from a […]